Fire crews were battling a large blaze Monday morning at a manufacturing facility in southwest suburban Joliet, Illinois. Firefighters from multiple departments responded to the blaze at Rovanco ...

The most popular injectable drugs already on the market are made by Eli Lilly, which sells its drug as Zepbound for obesity and Mounjaro for diabetes, and Novo Nordisk, which sells its medicine as ...

Every major city in China decides they need a solar panel factory, and the local government ... The fact that Novo Nordisk has created an extraordinary class of GLP 1 drugs is not a bad thing.

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s ... rather than inside the courtroom, would be a welcome ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Novo Nordisk is set to benefit from a $150B market by 2030, with strong earnings potential and a favorable 14x forward P/E.

The implications for Eli Lilly and Novo Nordisk seem pretty clear: The immediate removal of a rival for the massive revenues ...

https://www.tipranks.com/news/the-fly/novo-nordisk-warns-of-counterfeit-ozempic-injections Novo Nordisk (NVO) said it has become aware of several hundred units of ...

Accordingly, neither Novo Nordisk nor FDA can confirm the contents or quality of the counterfeit product, which may present a safety risk for patients who use the counterfeit product. Patients are ...

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer ...